Meth makers to be foiled by jelly

Specialty drugmaker Highland Pharmaceuticals says it's found a way to halt the production of meth cookers. The St. Louis company has developed a chemical lock of sorts that prevents meth-makers from extracting the "API" pseudoephedrine from common cold and allergy drugs such as Sudafed and Mucinex. The new pseudoephedrine-making process turns the substance into an unusable, jelly-like material when drug-cookers try to extract it. Story

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.